Follow
0 Job openings in Rezolute
About Rezolute
Rezolute is a clinical‑stage biopharmaceutical company developing transformative therapies—such as the monoclonal antibody ersodetug (RZ358) in Phase 3 for congenital hyperinsulinism and the oral plasma kallikrein inhibitor RZ402 in Phase 2 for diabetic macular edema—to treat rare metabolic and orphan diseases associated with dysregulated insulin and glucose balance.
